Literature DB >> 18762763

Palifermin in allogeneic HSCT: many questions remain.

W J F M van der Velden, A H E Herbers, N M A Blijlevens.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18762763     DOI： 10.1038/bmt.2008.269

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  4 in total

1.  Platelet lysate mucohadesive formulation to treat oral mucositis in graft versus host disease patients: a new therapeutic approach.

Authors:  Claudia Del Fante; Cesare Perotti; Maria Cristina Bonferoni; Silvia Rossi; Giuseppina Sandri; Franca Ferrari; Luigia Scudeller; Carla Marcella Caramella
Journal:  AAPS PharmSciTech       Date:  2011-07-06       Impact factor: 3.246

Review 2.  The FGF family: biology, pathophysiology and therapy.

Authors:  Andrew Beenken; Moosa Mohammadi
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

Review 3.  Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.

Authors:  Saroj Vadhan-Raj; Jenna D Goldberg; Miguel-Angel Perales; Dietmar P Berger; Marcel R M van den Brink
Journal:  J Cell Mol Med       Date:  2013-11-19       Impact factor: 5.310

Review 4.  Efficacy of palifermin in the hematopoietic stem cell transplant setting.

Authors:  Muneera Panjwani
Journal:  J Adv Pract Oncol       Date:  2013-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.